Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UKRAINE: Customs Service Charges Anti-AIDS Group Hr 3.3 Million for Syringes




 

KyivPost (01.28.13)

The Ukraine Ministry of Taxes and Fees has demanded that the International HIV/AIDS Alliance pay Hr 3.3 million in retroactive “anti-dumping” customs fees for syringes the alliance imported from a Spanish company in 2010. The Ministry of Taxes and Fees asserts that the alliance must pay customs fees established in 2009 for commercial purchases not specified as humanitarian relief. The alliance counters that the customs fees were intended for “products meant for sale,” whereas the alliance imported the syringes for free distribution to drug addicts to cut the risk of HIV infection due to syringe sharing. In addition, the alliance purchased the syringes while the fee was suspended due to a court challenge from commercial syringe importers. The 2010 cost for the imported syringes was $0.05 to $0.08 cents each, with no customs fee. In December 2012, local pharmaceutical companies won the anti-dumping suit, prompting the Ministry of Taxes and Fees to press for the alliance to pay back customs fees. Alliance representative Andriy Klepikov stated that the Global Fund, which supports the alliance’s HIV prevention efforts, might suspend alliance programs as a result of the taxation. Klepikov added that the quality of syringes manufactured in Ukraine was unsatisfactory. Each year, the alliance provides 120 syringes each to approximately 160,000 injection drug users, according to Iryna Malykh, alliance purchasing manager. Alliance representatives fear that cancellation of the syringe distribution program will result in increased incidence of HIV and TB in Ukraine. The alliance plans to challenge the retroactive customs fee in court.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in January 30, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.